Neoadjuvant Multikinase Inhibitor in Patients With Locally Advanced Unresectable Thyroid Carcinoma

Neoadjuvant Multikinase Inhibitor in Patients With Locally Advanced Unresectable Thyroid Carcinoma

Background: Papillary thyroid carcinoma (PTC) is the most common and less aggressive thyroid cancer, but some patients may display locally advanced disease. Therapeutic options are limited in these cases, particularly for those patients with unresectable tumors. Neoadjuvant therapy is not part of th...

Full description

Bibliographic Details
Main Authors: Carla Fernanda Nava, Rafael Selbach Scheffel, Ana Patrícia Cristo, Carla Vaz Ferreira, Shana Weber, André Borsatto Zanella, Francisco Costa Paixão, Alceu Migliavaca, José Ricardo Guimarães, Marcia Silveira Graudenz, José Miguel Dora, Ana Luiza Maia
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Endocrinology
Subjects:
thyroid carcinoma
multikinase inhibitors
neoadjuvant therapy
unresectable thyroid tumors
locally invasive thyroid tumors
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00712/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00712/full

Similar Items